These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L Coelho T; Ando Y; Benson MD; Berk JL; Waddington-Cruz M; Dyck PJ; Gillmore JD; Khella SL; Litchy WJ; Obici L; Monteiro C; Tai LJ; Viney NJ; Buchele G; Brambatti M; Jung SW; St L O'Dea L; Tsimikas S; Schneider E; Geary RS; Monia BP; Gertz M Neurol Ther; 2021 Jun; 10(1):375-389. PubMed ID: 33638113 [TBL] [Abstract][Full Text] [Related]
5. Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis). Gonzalez-Duarte A Clin Auton Res; 2019 Apr; 29(2):245-251. PubMed ID: 29511897 [TBL] [Abstract][Full Text] [Related]
6. Wild-Type Transthyretin Amyloidosis Occurring in the Ligamentum Flavum of the Cervicothoracic Spine. George KM; Dowd RS; Nail J; Yu A; Mastroianni M; Wang AY; Arkun K; Patel A; Kryzanski J; Comenzo R; Riesenburger RI World Neurosurg; 2020 Oct; 142():e325-e330. PubMed ID: 32652280 [TBL] [Abstract][Full Text] [Related]
7. Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis. Eldhagen P; Berg S; Lund LH; Sörensson P; Suhr OB; Westermark P J Intern Med; 2021 Jun; 289(6):895-905. PubMed ID: 33274477 [TBL] [Abstract][Full Text] [Related]
8. Tyr78Phe Transthyretin Mutation with Predominant Motor Neuropathy as the Initial Presentation. Riboldi G; Del Bo R; Ranieri M; Magri F; Sciacco M; Moggio M; Bresolin N; Corti S; Comi GP Case Rep Neurol; 2011 Feb; 3(1):62-8. PubMed ID: 21490715 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care. Luigetti M; Romano A; Di Paolantonio A; Bisogni G; Sabatelli M Ther Clin Risk Manag; 2020; 16():109-123. PubMed ID: 32110029 [TBL] [Abstract][Full Text] [Related]
10. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey. Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058 [TBL] [Abstract][Full Text] [Related]
11. Late-Onset Hereditary Transthyretin Amyloidosis Val30Met in an Elderly Person in a Non-Endemic Area. Wang S; Sun J; Lu Q; Li H; Zhang Y Int Med Case Rep J; 2022; 15():299-306. PubMed ID: 35734096 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosis. Marchi F; Kessler C; Distefano D; Terzi di Bergamo L; Fumagalli L; Averaimo M; Crupi E; Bergamini F; Melli G; Stussi G; Rossi D; Gobbi C; Ripellino P; Pravatà E; Kuhlen DE; Röcken C; Scarone P; Gerber B; Condoluci A Amyloid; 2023 Dec; 30(4):416-423. PubMed ID: 37431662 [TBL] [Abstract][Full Text] [Related]
14. Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS + 7. Dyck PJB; González-Duarte A; Obici L; Polydefkis M; Wiesman JF; Antonino I; Litchy WJ; Dyck PJ J Neurol Sci; 2019 Oct; 405():116424. PubMed ID: 31445300 [TBL] [Abstract][Full Text] [Related]
15. Amyloid Deposits in the Ligamentum Flavum Related to Lumbar Spinal Canal Stenosis and Lumbar Disc Degeneration. Al Yaseen M; Al Zahid H; Al-Haroon S Cureus; 2022 Jun; 14(6):e26221. PubMed ID: 35911371 [TBL] [Abstract][Full Text] [Related]
16. "Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathy. Conceição I; González-Duarte A; Obici L; Schmidt HH; Simoneau D; Ong ML; Amass L J Peripher Nerv Syst; 2016 Mar; 21(1):5-9. PubMed ID: 26663427 [TBL] [Abstract][Full Text] [Related]
17. Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis. Westermark P; Westermark GT; Suhr OB; Berg S Ups J Med Sci; 2014 Aug; 119(3):223-8. PubMed ID: 24620715 [TBL] [Abstract][Full Text] [Related]
18. hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers. Luigetti M; Romozzi M; Bisogni G; Cardellini D; Cavallaro T; Di Paolantonio A; Fabrizi GM; Fenu S; Gentile L; Grandis M; Marucci G; Massucco S; Mazzeo A; Pareyson D; Romano A; Russo M; Schenone A; Tagliapietra M; Tozza S; Vita G; Sabatelli M Brain Sci; 2020 Oct; 10(11):. PubMed ID: 33114611 [TBL] [Abstract][Full Text] [Related]
19. Variable Presentation of Hereditary Transthyretin-Mediated Amyloidosis at a Single Center. Hussain Y J Clin Neuromuscul Dis; 2021 Sep; 23(1):7-17. PubMed ID: 34431796 [TBL] [Abstract][Full Text] [Related]
20. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Coelho T; Maurer MS; Suhr OB Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]